Evolving Treatment Paradigms for Gynecologic Cancers: Application for Current and Future Practice

Join us for this 1.5 hour interactive live satellite symposium featuring expert perspectives on the latest data on managing patients with cervical, endometrial, and ovarian cancers, including discussion around patient cases and the opportunity to get your questions answered by the experts.

This live satellite symposium, “Evolving Treatment Paradigms for Gynecologic Cancers: Application for Current and Future Practice,” will feature expert faculty and will provide interactivity, evidence-based content, and a Q&A session. Learners can submit their questions directly to the faculty, and the planned agenda allows time for the faculty to discuss and answer attendees questions.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right-hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Symposium/Webinar.

Not an official event of the 2022 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO®, CancerLinQ®, or Conquer Cancer® the ASCO Foundation.

Agenda

Welcome, Introduction, Polling, and Presurvey Questions

Advances in Current Management of Endometrial Cancers

  • Advances in the treatment landscape
    • New clinical data
    • New approvals
  • Management of immune-related AEs
  • Novel therapies in development
    • Case-based discussion of current data

Advances in Frontline and Recurrent Ovarian Cancers

  • Testing for BRCA1/2 and HRD status
  • PARPi in frontline and recurrent ovarian cancer
  • Novel therapies in development
    • Case-based discussion of current data

Advances in Current Management of Cervical Cancers

  • Cervix cancer overview
    • HPV Infection and tumorigenesis
    • HPV vaccination and preventative measures
  • Current treatments algorithms for advanced/metastatic cervix cancer
  • Novel therapies in development
    • Immunotherapy
    • Antibody–drug conjugates
    • PARP inhibitors
    • Case-based discussion of current data

Audience Q&A Session

Events

Date / Time
Event Details

Faculty

Program Director
David Scott Miller, MD, FACOG, FACS

Amy and Vernon E. Faulconer Distinguished Chair in Medical Science
Director and Dallas Foundation Chair in Gynecologic Oncology
Professor of Obstetrics & Gynecology
Fred F. Florence Bioinformation Center
University of Texas Southwestern Medical Center
Medical Director of Gynecologic Oncology
Chair, 
Cancer Committee
Parkland Health & Hospital System
Dallas, Texas

Faculty
Nicoletta Colombo, MD

Professor of Obstetrics and Gynecology
University of Milan-Bicocca
European Institute of Oncology
Milan, Italy

Faculty
Shannon N. Westin, MD, MPH

Associate Professor
Division of Surgery
Department of Gynecologic Oncology and Reproductive Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

Goal Statement
The goal of this activity is to improve the knowledge, confidence, and competence of learners in selecting individualized treatment regimens for patients with gynecologic malignancies.

Target Audience
This educational program is intended for medical oncologists and other HCPs who treat patients with gynecologic cancer.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Assess appropriate predictive biomarkers in gynecologic cancers to guide treatment selection and clinical trial eligibility
  • Evaluate available practice-changing clinical data on new targeted therapies as single-agent or combination therapies in cervical, endometrial, and ovarian cancer
  • Plan treatment strategies for patients with cervical, endometrial, and ovarian cancers that incorporate novel therapies and combination strategies
  • Select maintenance therapy for patients with ovarian cancer with or without BRCA mutations or other homologous recombination repair deficiencies in the frontline and relapsed settings
  • Describe the role of ICI-based therapy in endometrial cancer classified as microsatellite stable

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Designation of Credit

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.